# References

Deepika, Deepika, and Vikas Kumar. “The Role of “Physiologically Based Pharmacokinetic Model (PBPK)” New Approach Methodology (NAM) in Pharmaceuticals and Environmental Chemical Risk Assessment.” International Journal of Environmental Research and Public Health, vol. 20, no. 4, 16 Feb. 2023, p. 3473, www.ncbi.nlm.nih.gov/pmc/articles/PMC9966583/, https://doi.org/10.3390/ijerph20043473.

Jamei, M. et al. "Population-based mechanistic prediction of oral drug absorption." The AAPS Journal, vol. 11, no. 2, 2009, pp. 225–237, https://doi:10.1208/s12248-009-9099-y.

Jones, H. M., and K. Rowland Yeo. "Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development." CPT: Pharmacometrics & Systems Pharmacology, vol. 2, no. 8, 2013, pp. 1–12, https://doi:10.1038/psp.2013.41.

Jones, Hannah M, et al. “A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics.” Clinical Pharmacokinetics, vol. 45, no. 5, 2006, pp. 511–542, https://doi.org/10.2165/00003088-200645050-00006.

Lee, Myongjae, et al. “Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics.” Pharmaceutics, vol. 14, no. 6, 28 May 2022, p. 1157, https://doi.org/10.3390/pharmaceutics14061157. 

Reigner, B., et al. "Comparative pharmacokinetics of propranolol after administration into the portal and systemic circulation in the rat." Journal of Pharmacology, vol. 38, no. 2, 1989, pp. 112–119, https://doi:10.1159/000136352.

Rostami-Hodjegan, A. "Physiologically based pharmacokinetics joined with in vitro–in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology." Clinical Pharmacology & Therapeutics, vol. 92, no. 1, 2012, pp. 50–61, https://doi:10.1038/clpt.2012.65.

Rowland, M., et al. "Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report." Clinical Pharmacokinetics, vol. 45, no. 5, 2006, pp. 507–526, https://doi:10.2165/00003088-200645050-00006.

Rowland, M., and T. N. Tozer. "Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications." 4th ed., Wolters Kluwer Health/Lippincott Williams & Wilkins, 2011.

Shand, D.G, et al. “The Disposition of Propranolol.” Pharmacology, vol. 8, no. 4-6, 1 Jan. 1972, pp. 344–352, https://doi.org/10.1159/000136352.

Taegtmeyer, Anne B, et al. "A Study of the Relationship between Serum Bile Acids and Propranolol Pharmacokinetics and Pharmacodynamics in Patients with Liver Cirrhosis and in Healthy Controls." Vol. 9, no. 6, 6 June 2014, pp. e97885–e97885, https://doi.org/10.1371/journal.pone.0097885.

Zhao, Peng, et al. "Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review." Clinical Pharmacology & Therapeutics, vol. 92, no. 1, 2012, pp. 1–4, https://doi:10.1038/clpt.2012.113.
